Latest EYLEA Stories
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
DME is the third approved indication for EYLEA in the U.S. TARRYTOWN, N.Y., July 29, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
a team of ophthalmologists at the University of Iowa has shown that Eylea an ease leaking and vision problems for wet AMD patients.
- The word or words serving to define another word or expression, as in a dictionary entry.